Indeed, VEGF directly suppresses various immune cells present in the tumour microenvironment, contributes to tumour associated immune deficiency, inhibits the antigen presentation process by DCs; induces apoptotic death in CD8+ T cells and promotes the activity of T regulatory cells (Tregs). Here, VEGFA is linked to neoplasm.